$130.00
BPC-157 + TB-500 + GHK-Cu + KPV
Contents: 80 mg | BPC-157 (10mg) + TB-500 (10mg) + GHK-Cu (50mg) + KPV (10mg)
Formato: Polvo liofilizado
Pureza: ≥ 99% Probado en EE. UU., Pureza Verificada (Probada mediante HPLC)
Verificación: Certificados de Autenticidad Verificables ((Emparejados por Lote)
Nuevas evidencias de investigación:
The KLOW research blend is studied in laboratory models to investigate integrated tissue restoration and inflammatory-signaling pathways. Researchers examine how the combined analytes influence collagen synthesis, microcirculation, dermal remodeling, and mucosal barrier integrity. Ongoing investigations focus on coordinated cellular signaling across connective tissue, skin, and gut-immune interfaces in controlled experimental settings.
Mantener el producto en un lugar fresco y oscuro.
Solo para Uso en Investigación / No Regulado por la FDA
Inventario Verificado por Lotes.. Ver 3rd Ver COA de 3ª Parte.
En stock
⚠️ Requiere agua estéril para su reconstitución.
Solo para uso en laboratorio.
KLOW is studied in pre-clinical models as a comprehensive structural repair blueprint that coordinates multiple cellular signaling pathways at once. By combining GHK-Cu, BPC-157, TB-500, and KPV, this blend allows researchers to observe the accelerated stabilization of the cellular framework and the mapping of complex tissue-repair dynamics. The primary research benefit of this formulation is its ability to simulate full-system recovery coordination, providing high-resolution data on how structural rebuilding, signaling balance, and barrier protection intersect. These investigations focus on the positive synchronization of recovery markers and structural remodeling in laboratory environments, without reference to therapeutic outcomes or clinical efficacy.
(15-aa “Body Protection Compound” fragment)
Research Focus:
Connective tissue signaling
Cytoprotective pathway evaluation
Inflammatory-response modulation
(N-acetyl-LKKTETQ; thymosin-β4 fragment 17–23)
Research Focus:
Actin-binding and cellular migration pathways
Angiogenic signaling models
Soft-tissue structural remodeling
(Copper(II) tripeptide complex of Gly-His-Lys)
Research Focus:
Dermal matrix remodeling
Collagen-related gene signaling
Oxidative-stress response pathways
(α-MSH fragment 11–13)
Research Focus:
Anti-inflammatory signaling pathways
Epithelial barrier and mucosal integrity models
Host-defense peptide signaling
Multi-pathway tissue regeneration biology
Inflammatory pathway regulation
Structural ECM remodeling
Dermal and connective-tissue signaling
Gut-immune axis modulation
KLOW se utiliza como una herramienta de precisión de multi-pathway blueprint for studying the coordinated signaling of tissue regeneration and structural rebuilding. In laboratory models, this blend allows researchers to track how different cellular signals work together to stabilize the framework and protect the internal environment. These investigations focus on mapping the synchronized flow of repair messages—specifically how the cellular matrix and protective pathways interact—to understand the foundation of recovery, without reference to therapeutic or clinical outcomes.
Nota solo para fines de investigación: KLOW is not FDA-approved for therapeutic use. Published effects are primarily preclinical and exploratory.
Solo para fines de investigación — No apto para uso humano ni veterinario. No evaluado ni aprobado por la FDA. No está destinado a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Toda la información de este sitio web se proporciona exclusivamente con fines educativos y de investigación de laboratorio. Nada de lo aquí expuesto constituye asesoramiento médico, clínico o legal, ni un respaldo para su uso fuera del laboratorio. Cualquier mención de péptidos específicos o posibles hallazgos de investigación tiene únicamente fines informativos y no debe interpretarse como una guía para su uso en humanos o animales.